Baseline patients’ characteristics by hospital admission
| Status . | Overall n (%) . | Admitted n (%) . | Not-admitted n (%) . | P-value . |
|---|---|---|---|---|
| 856 (100) | 468 (55) | 388 (45) | ||
| Median age (range) | 63 | 67 | 57 | <.001 |
| (19-94) | (20-92) | (19-94) | ||
| Gender | <.001 | |||
| Male | 504 (59) | 305 (65) | 199 (51) | |
| Charlson Index | <.001 | |||
| >6 | 166 (20) | 123 (28) | 43 (11) | |
| Anemia | <.001 | |||
| <12 g/dL | 122 (16) | 95 (22) | 27 (8) | |
| Total lymphocytes | ||||
| <650/mmc | 140 (22) | 105 (28) | 35 (12) | <.001 |
| Histology | ||||
| DLBCL | 251 (29) | 147 (31) | 104 (27) | .152 |
| FL | 183 (21) | 111 (24) | 72 (19) | .078 |
| HG-NOS, DHL | 55 (6) | 34 (7) | 21 (5) | .327 |
| MZL | 72 (8) | 48 (10) | 24 (6) | .036 |
| LPL | 61 (7) | 32 (7) | 29 (7) | .790 |
| MCL | 60 (7) | 34 (7) | 26 (7) | .789 |
| T-cell | 47 (5) | 28 (6) | 19 (5) | .530 |
| cHL | 115 (13) | 28 (6) | 87 (22) | <.001 |
| LP-HL | 11 (1) | 6 (1) | 5 (1) | 1.00 |
| Smoker | .008 | |||
| Never | 429 (70) | 199 (66) | 230 (75) | |
| Former | 128 (21) | 79 (26) | 49 (16) | |
| Current | 53 (9) | 24 (8) | 29 (9) | |
| COVID-19 severity | <.001 | |||
| Mild | 505 (63) | 184 (40) | 321 (92) | |
| Severe | 230 (29) | 206 (45) | 24 (7) | |
| Critical | 68 (8) | 66 (14) | 2 (1) | |
| # line treatment | .428 | |||
| 1 | 345 (69) | 189 (72) | 156 (65) | |
| 2 | 87 (17) | 41 (16) | 46 (19) | |
| 3 | 39 (8) | 18 (7) | 21 (9) | |
| 4+ | 32 (6) | 15 (6) | 17 (87) | |
| Time to COVID-19 | <.001 | |||
| ≤3 mo | 138 (16) | 99 (21) | 39 (10) | |
| 3-12 mo | 188 (22) | 113 (24) | 75 (19) | |
| 12-24 mo | 133 (16) | 68 (15) | 65 (17) | |
| 24-36 mo | 73 (9) | 46 (10) | 27 (7) | |
| 36-48 mo | 58 (7) | 17 (4) | 41 (11) | |
| >48 mo | 259 (31) | 119 (25) | 140 (36) | |
| Status at COVID-19 | <.001 | |||
| CR | 374 (46) | 159 (36) | 215 (57) | |
| PR | 137 (17) | 89 (20) | 48 (13) | |
| SD | 98 (12) | 64 (15) | 34 (9) | |
| PD | 120 (15) | 82 (19) | 38 (10) | |
| W&W | 83 (10) | 44 (10) | 39 (10) |
| Status . | Overall n (%) . | Admitted n (%) . | Not-admitted n (%) . | P-value . |
|---|---|---|---|---|
| 856 (100) | 468 (55) | 388 (45) | ||
| Median age (range) | 63 | 67 | 57 | <.001 |
| (19-94) | (20-92) | (19-94) | ||
| Gender | <.001 | |||
| Male | 504 (59) | 305 (65) | 199 (51) | |
| Charlson Index | <.001 | |||
| >6 | 166 (20) | 123 (28) | 43 (11) | |
| Anemia | <.001 | |||
| <12 g/dL | 122 (16) | 95 (22) | 27 (8) | |
| Total lymphocytes | ||||
| <650/mmc | 140 (22) | 105 (28) | 35 (12) | <.001 |
| Histology | ||||
| DLBCL | 251 (29) | 147 (31) | 104 (27) | .152 |
| FL | 183 (21) | 111 (24) | 72 (19) | .078 |
| HG-NOS, DHL | 55 (6) | 34 (7) | 21 (5) | .327 |
| MZL | 72 (8) | 48 (10) | 24 (6) | .036 |
| LPL | 61 (7) | 32 (7) | 29 (7) | .790 |
| MCL | 60 (7) | 34 (7) | 26 (7) | .789 |
| T-cell | 47 (5) | 28 (6) | 19 (5) | .530 |
| cHL | 115 (13) | 28 (6) | 87 (22) | <.001 |
| LP-HL | 11 (1) | 6 (1) | 5 (1) | 1.00 |
| Smoker | .008 | |||
| Never | 429 (70) | 199 (66) | 230 (75) | |
| Former | 128 (21) | 79 (26) | 49 (16) | |
| Current | 53 (9) | 24 (8) | 29 (9) | |
| COVID-19 severity | <.001 | |||
| Mild | 505 (63) | 184 (40) | 321 (92) | |
| Severe | 230 (29) | 206 (45) | 24 (7) | |
| Critical | 68 (8) | 66 (14) | 2 (1) | |
| # line treatment | .428 | |||
| 1 | 345 (69) | 189 (72) | 156 (65) | |
| 2 | 87 (17) | 41 (16) | 46 (19) | |
| 3 | 39 (8) | 18 (7) | 21 (9) | |
| 4+ | 32 (6) | 15 (6) | 17 (87) | |
| Time to COVID-19 | <.001 | |||
| ≤3 mo | 138 (16) | 99 (21) | 39 (10) | |
| 3-12 mo | 188 (22) | 113 (24) | 75 (19) | |
| 12-24 mo | 133 (16) | 68 (15) | 65 (17) | |
| 24-36 mo | 73 (9) | 46 (10) | 27 (7) | |
| 36-48 mo | 58 (7) | 17 (4) | 41 (11) | |
| >48 mo | 259 (31) | 119 (25) | 140 (36) | |
| Status at COVID-19 | <.001 | |||
| CR | 374 (46) | 159 (36) | 215 (57) | |
| PR | 137 (17) | 89 (20) | 48 (13) | |
| SD | 98 (12) | 64 (15) | 34 (9) | |
| PD | 120 (15) | 82 (19) | 38 (10) | |
| W&W | 83 (10) | 44 (10) | 39 (10) |
CI, comorbidity index; histology abbreviations, see supplemental Material.
Continuous data: Mann-Whitney U test; categorical data: Fisher's exact test. For histology test single group vs others.